派格生物医药-B完成发行合共513.6万股配售股份

Group 1 - The core viewpoint of the article is that Pagoda Biopharmaceuticals-B (02565) has successfully completed a placement agreement on December 22, 2025 [1] - The placement involved the issuance of 5.136 million shares at a price of HKD 58.41 per share [1] - This placement represents approximately 1.81% of the enlarged H-shares and about 1.31% of the total shares post-placement [1]